No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Nova Eye Medical Ltd: Investor Presentation 30 June 2024 Results
Nova Eye Medical Ltd: Full Year Financial Results
Nova Eye Medical Ltd: Appendix 4E and Annual Report
Nova Eye Medical's Glaucoma Division Sees 37% Rise in Sales for Fiscal 2024
Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 37% Undervaluation?
Newsflash: Nova Eye Medical Limited (ASX:EYE) Analysts Have Been Trimming Their Revenue Forecasts
No Data